Kindstar Globalgene Technology (9960.HK) Earnings Analysis
Kindstar Globalgene Technology (9960.HK) next reports earnings on 2026-09-02, consensus EPS 0.04682 HKD. Trailing P/E -14.43.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 9960.HK next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | 0.04682 HKD |
| Revenue estimate | 0.62B |
9960.HK earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
9960.HK valuation and analyst view
| Trailing P/E | -14.43 |
|---|---|
| Trailing EPS | -0.05703 HKD |
| Price / book | 0.33 |
| Dividend yield | 9.50% |
| Market cap | 1.03B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Kindstar Globalgene Technology (9960.HK)'s next earnings date?
Kindstar Globalgene Technology is next scheduled to report on 2026-09-02, with a consensus EPS estimate of 0.04682 HKD and revenue estimate of 0.62B.
What is 9960.HK's current P/E ratio and EPS?
9960.HK trades at a trailing P/E of -14.43 on trailing EPS of -0.057034338575930085 HKD.
What do analysts rate 9960.HK?
9960.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.